GOOGL
48
-5
ORLY
60
-5
USB
50
-3
FIS
51
-4
MSI
72
-3
AIV
64
4
AIZ
82
2
WU
24
4
GILD
47
-8
D
40
2
MUR
44
-3
LB
30
4
SCHW
62
-2
RRC
52
-6
CA
22
-3
WDC
37
-3
WYNN
36
-5
EXPD
43
-4
ESS
62
-3
DG
8
-2
GOOGL
48
-5
ORLY
60
-5
USB
50
-3
FIS
51
-4
MSI
72
-3
AIV
64
4
AIZ
82
2
WU
24
4
GILD
47
-8
D
40
2
MUR
44
-3
LB
30
4
SCHW
62
-2
RRC
52
-6
CA
22
-3
WDC
37
-3
WYNN
36
-5
EXPD
43
-4
ESS
62
-3
DG
8
-2
Financhill
Back

SPDR® MSCI EAFE StrategicFactors ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

QEFA
SPDR® MSCI EAFE StrategicFactors ETF

Last Price:
74.42
Seasonality Move:
1.67%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
SPDR® MSCI EAFE StrategicFactors ETF (QEFA) is a Sell

Is SPDR® MSCI EAFE StrategicFactors ETF a Buy, Sell or Hold?

  • The current SPDR® MSCI EAFE StrategicFactors ETF [QEFA] share price is $74.35. The Score for QEFA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • QEFA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QEFA Stock Price Chart

What is SPDR® MSCI EAFE StrategicFactors ETF's stock price today?

  • The SPDR® MSCI EAFE StrategicFactors ETF share price today is $74.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QEFA is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

QEFA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.98 Sell
Relative Strength Index (14 RSI): 32.79 Sell
Chaikin Money Flow: 6751 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.65 - 78.37) Sell
Bollinger Bands (100): (75.65 - 79.43) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

QEFA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.56 Sell
20-day SMA: 76.55 Sell
50-day SMA: 78.24 Sell
200-day SMA: 76.33 Sell
8-day EMA: 75.36 Sell
20-day EMA: 76.43 Sell
50-day EMA: 77.4 Sell
200-day EMA: 76.01 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

SPDR® MSCI EAFE StrategicFactors ETF Earnings Growth & QEFA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

SPDR® MSCI EAFE StrategicFactors ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):